2587 related articles for article (PubMed ID: 33408181)
1. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan JM; Mateus J; Kato Y; Hastie KM; Yu ED; Faliti CE; Grifoni A; Ramirez SI; Haupt S; Frazier A; Nakao C; Rayaprolu V; Rawlings SA; Peters B; Krammer F; Simon V; Saphire EO; Smith DM; Weiskopf D; Sette A; Crotty S
Science; 2021 Feb; 371(6529):. PubMed ID: 33408181
[TBL] [Abstract][Full Text] [Related]
2. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection.
Ansari A; Arya R; Sachan S; Jha SN; Kalia A; Lall A; Sette A; Grifoni A; Weiskopf D; Coshic P; Sharma A; Gupta N
Front Immunol; 2021; 12():636768. PubMed ID: 33777028
[TBL] [Abstract][Full Text] [Related]
3. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
Front Immunol; 2022; 13():817905. PubMed ID: 35185909
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.
Cohen KW; Linderman SL; Moodie Z; Czartoski J; Lai L; Mantus G; Norwood C; Nyhoff LE; Edara VV; Floyd K; De Rosa SC; Ahmed H; Whaley R; Patel SN; Prigmore B; Lemos MP; Davis CW; Furth S; O'Keefe JB; Gharpure MP; Gunisetty S; Stephens K; Antia R; Zarnitsyna VI; Stephens DS; Edupuganti S; Rouphael N; Anderson EJ; Mehta AK; Wrammert J; Suthar MS; Ahmed R; McElrath MJ
Cell Rep Med; 2021 Jul; 2(7):100354. PubMed ID: 34250512
[TBL] [Abstract][Full Text] [Related]
5. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
[TBL] [Abstract][Full Text] [Related]
8. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
Yao L; Wang GL; Shen Y; Wang ZY; Zhan BD; Duan LJ; Lu B; Shi C; Gao YM; Peng HH; Wang GQ; Wang DM; Jiang MD; Cao GP; Ma MJ
J Infect Dis; 2021 Aug; 224(4):586-594. PubMed ID: 33978754
[TBL] [Abstract][Full Text] [Related]
9. Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.
Dan JM; Mateus J; Kato Y; Hastie KM; Yu ED; Faliti CE; Grifoni A; Ramirez SI; Haupt S; Frazier A; Nakao C; Rayaprolu V; Rawlings SA; Peters B; Krammer F; Simon V; Saphire EO; Smith DM; Weiskopf D; Sette A; Crotty S
bioRxiv; 2020 Dec; ():. PubMed ID: 33442687
[TBL] [Abstract][Full Text] [Related]
10. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
11. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Wang Z; Muecksch F; Schaefer-Babajew D; Finkin S; Viant C; Gaebler C; Hoffmann HH; Barnes CO; Cipolla M; Ramos V; Oliveira TY; Cho A; Schmidt F; Da Silva J; Bednarski E; Aguado L; Yee J; Daga M; Turroja M; Millard KG; Jankovic M; Gazumyan A; Zhao Z; Rice CM; Bieniasz PD; Caskey M; Hatziioannou T; Nussenzweig MC
Nature; 2021 Jul; 595(7867):426-431. PubMed ID: 34126625
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antibody immunity to SARS-CoV-2.
Gaebler C; Wang Z; Lorenzi JCC; Muecksch F; Finkin S; Tokuyama M; Cho A; Jankovic M; Schaefer-Babajew D; Oliveira TY; Cipolla M; Viant C; Barnes CO; Bram Y; Breton G; Hägglöf T; Mendoza P; Hurley A; Turroja M; Gordon K; Millard KG; Ramos V; Schmidt F; Weisblum Y; Jha D; Tankelevich M; Martinez-Delgado G; Yee J; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Robbiani DF; Zhao Z; Gazumyan A; Schwartz RE; Hatziioannou T; Bjorkman PJ; Mehandru S; Bieniasz PD; Caskey M; Nussenzweig MC
Nature; 2021 Mar; 591(7851):639-644. PubMed ID: 33461210
[TBL] [Abstract][Full Text] [Related]
13. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
[TBL] [Abstract][Full Text] [Related]
14. Rapid induction of antigen-specific CD4
Painter MM; Mathew D; Goel RR; Apostolidis SA; Pattekar A; Kuthuru O; Baxter AE; Herati RS; Oldridge DA; Gouma S; Hicks P; Dysinger S; Lundgreen KA; Kuri-Cervantes L; Adamski S; Hicks A; Korte S; Giles JR; Weirick ME; McAllister CM; Dougherty J; Long S; D'Andrea K; Hamilton JT; Betts MR; Bates P; Hensley SE; Grifoni A; Weiskopf D; Sette A; Greenplate AR; Wherry EJ
Immunity; 2021 Sep; 54(9):2133-2142.e3. PubMed ID: 34453880
[TBL] [Abstract][Full Text] [Related]
15. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.
Rodda LB; Netland J; Shehata L; Pruner KB; Morawski PA; Thouvenel CD; Takehara KK; Eggenberger J; Hemann EA; Waterman HR; Fahning ML; Chen Y; Hale M; Rathe J; Stokes C; Wrenn S; Fiala B; Carter L; Hamerman JA; King NP; Gale M; Campbell DJ; Rawlings DJ; Pepper M
Cell; 2021 Jan; 184(1):169-183.e17. PubMed ID: 33296701
[TBL] [Abstract][Full Text] [Related]
16. Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Pradenas E; Trinité B; Urrea V; Marfil S; Tarrés-Freixas F; Ortiz R; Rovirosa C; Rodon J; Vergara-Alert J; Segalés J; Guallar V; Valencia A; Izquierdo-Useros N; Noguera-Julian M; Carrillo J; Paredes R; Mateu L; Chamorro A; Toledo R; Massanella M; Clotet B; Blanco J
Cell Rep Med; 2022 Feb; 3(2):100523. PubMed ID: 35233547
[TBL] [Abstract][Full Text] [Related]
17. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
18. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
19. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.
Paniskaki K; Anft M; Meister TL; Marheinecke C; Pfaender S; Skrzypczyk S; Seibert FS; Thieme CJ; Konik MJ; Dolff S; Anastasiou O; Holzer B; Dittmer U; Queren C; Fricke L; Rohn H; Westhoff TH; Witzke O; Stervbo U; Roch T; Babel N
Front Immunol; 2022; 13():816220. PubMed ID: 35145522
[TBL] [Abstract][Full Text] [Related]
20. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
Jiang XL; Wang GL; Zhao XN; Yan FH; Yao L; Kou ZQ; Ji SX; Zhang XL; Li CB; Duan LJ; Li Y; Zhang YW; Duan Q; Wang TC; Li ET; Wei X; Wang QY; Wang XF; Sun WY; Gao YW; Kang DM; Zhang JY; Ma MJ
Nat Commun; 2021 Feb; 12(1):897. PubMed ID: 33563974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
